Rena C Moon1, Linda Lastrapes1, Jameson Wier1, Mark Nakajima2, Wyatt Gaskins1, Andre F Teixeira1, Muhammad A Jawad3. 1. Department of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, 89 Copeland Dr, 1st Floor, Orlando, FL, USA. 2. Wolverine Anesthesia Consultants Inc, Orlando, FL, USA. 3. Department of Bariatric Surgery, Orlando Regional Medical Center, Orlando Health, 89 Copeland Dr, 1st Floor, Orlando, FL, USA. muhammad.jawad@orlandohealth.com.
Abstract
INTRODUCTION: Postoperative pain remains the most common challenge following inpatient and outpatient surgeries, and, therefore, opioid analgesics are widely used during the perioperative period. The aim of this study is to examine the efficiency of transversus abdominis plane (TAP) block using liposomal bupivacaine in reducing the use of opioid analgesics during the perioperative period of bariatric procedures. MATERIAL AND METHODS: A retrospective chart review was performed on 191 patients who underwent a laparoscopic bariatric procedure between September 13, 2017, and February 26, 2018. A total of 97 patients received TAP block with liposomal bupivacaine, and 94 patients did not receive TAP block. RESULTS: Baseline patient characteristics were comparable between the two groups. The mean age was 43.7 and 41.1 years, and the mean preoperative body mass index (BMI) was 45.6 and 46.1 kg/m2 in TAP and non-TAP groups, respectively. In the TAP group, 65 patients (69.2%) received intravenous (IV) hydromorphone or morphine while 93 (95.9%) did in the non-TAP group (p < 0.0001). In the TAP group, 44 (46.8%) received oral opioid analgesic while 73 (75.3%) did in the non-TAP group (p < 0.0001). The odds of receiving IV hydromorphone or morphine for TAP group was about 0.10 times the corresponding odds for non-TAP group, and the odds of receiving oral opioid analgesic for the TAP group was about 0.29 times the corresponding odds for the non-TAP group. CONCLUSION: The use of preoperative TAP block with liposomal bupivacaine significantly decreased the use of IV and oral opioid analgesics. A larger prospective study may be needed to further validate the results.
INTRODUCTION: Postoperative pain remains the most common challenge following inpatient and outpatient surgeries, and, therefore, opioid analgesics are widely used during the perioperative period. The aim of this study is to examine the efficiency of transversus abdominis plane (TAP) block using liposomal bupivacaine in reducing the use of opioid analgesics during the perioperative period of bariatric procedures. MATERIAL AND METHODS: A retrospective chart review was performed on 191 patients who underwent a laparoscopic bariatric procedure between September 13, 2017, and February 26, 2018. A total of 97 patients received TAP block with liposomal bupivacaine, and 94 patients did not receive TAP block. RESULTS: Baseline patient characteristics were comparable between the two groups. The mean age was 43.7 and 41.1 years, and the mean preoperative body mass index (BMI) was 45.6 and 46.1 kg/m2 in TAP and non-TAP groups, respectively. In the TAP group, 65 patients (69.2%) received intravenous (IV) hydromorphone or morphine while 93 (95.9%) did in the non-TAP group (p < 0.0001). In the TAP group, 44 (46.8%) received oral opioid analgesic while 73 (75.3%) did in the non-TAP group (p < 0.0001). The odds of receiving IV hydromorphone or morphine for TAP group was about 0.10 times the corresponding odds for non-TAP group, and the odds of receiving oral opioid analgesic for the TAP group was about 0.29 times the corresponding odds for the non-TAP group. CONCLUSION: The use of preoperative TAP block with liposomal bupivacaine significantly decreased the use of IV and oral opioid analgesics. A larger prospective study may be needed to further validate the results.
Authors: Eric Albrecht; Kyle R Kirkham; Ryan V W Endersby; Vincent W S Chan; Timothy Jackson; Allan Okrainec; Todd Penner; Rongyu Jin; Richard Brull Journal: Obes Surg Date: 2013-08 Impact factor: 4.129
Authors: Jaime Ruiz-Tovar; Alejandro Garcia; Carlos Ferrigni; Juan Gonzalez; Cesar Levano-Linares; Montiel Jimenez-Fuertes; Carolina Llavero; Manuel Duran Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: Michael Wassef; David Y Lee; Jun L Levine; Ronald E Ross; Hamza Guend; Catherine Vandepitte; Admir Hadzic; Julio Teixeira Journal: J Pain Res Date: 2013-11-27 Impact factor: 3.133
Authors: Karsten Bartels; Lena M Mayes; Colleen Dingmann; Kenneth J Bullard; Christian J Hopfer; Ingrid A Binswanger Journal: PLoS One Date: 2016-01-29 Impact factor: 3.240
Authors: Jaime Ruiz-Tovar; Gilberto Gonzalez; Andrei Sarmiento; Miguel A Carbajo; Javier Ortiz-de-Solorzano; Maria Jose Castro; Jose Maria Jimenez; Lorea Zubiaga Journal: Surg Endosc Date: 2020-01-13 Impact factor: 4.584